In Vitro Evaluation of Antifungal Drug Combinations against Sarocladium (Acremonium) kiliense, an Opportunistic Emergent Fungus Resistant to Antifungal Therapies
Author(s) -
Fabiola FernándezSilva,
Javier Capilla,
Emilio Mayayo,
Deanna A. Sutton,
Josep Guarro
Publication year - 2013
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02131-13
Subject(s) - acremonium , antifungal , fungus , biology , fungi imperfecti , echinocandins , microbiology and biotechnology , antifungal drug , in vitro , fungicide , drug resistance , amphotericin b , botany , caspofungin , biochemistry
Sarocladium kiliense, formerly known as Acremonium kiliense ([1][1]), is a ubiquitous soil saprophyte commonly found in the environment and occasionally infecting humans ([2][2]). Its pathogenicity in immunocompetent patients is low and usually is related to inoculation of the fungus via a
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom